key ingredients to
  effective vaccines

  benefits of adjuvants

  current vaccine

  our solutions


  key scientists


  tb vaccine

  leishmaniasis vaccine

  leprosy vaccine


  tb diagnostics

  leishmania diagnostics

  leprosy diagnostics

  chagas diagnostics

  sales contact


  tb drug discovery

  lilly tb drug
  discovery initiative

      about us

      working with us

      aproach to IP


Our Products

We target diseases that kill more than six million people each year. Although these diseases have different etiologies, symptoms, global footprints, and challenges, we have a singular goal for each program: developing diagnostic tests, vaccines, and therapeutic products that save lives and improve health outcomes.

Product Pipeline


Adjuvants: Key Ingredients to Effective Vaccines

As part of our vaccine platform, we work on adjuvant development. We have developed multiple adjuvant formulations, and are working with collaborators in various disease areas spanning preclinical studies and clinical trials. more

1616 Eastlake Avenue East, Suite 400, Seattle, Washington 98102  |  P: (206) 381-0883  |  F: (206) 381-3678 © 1993-2015 Privacy Policy
Infectious Disease Research Institute